Fig. 3: Swimmer plots showing the antitumor activity of pembrolizumab plus vorinostat by cancer type. | Nature Cancer

Fig. 3: Swimmer plots showing the antitumor activity of pembrolizumab plus vorinostat by cancer type.

From: Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial

Fig. 3

a, Head and neck cancer (N = 26 patients). b, Anal cancer (N = 29 patients). c, Cervical cancer (N = 23 patients). d, Vulvar/vaginal cancer (N = 16 patients). e, Penile cancer (N = 11 patients). No statistical test was used.

Source data

Back to article page